NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

from NutraIngredients NutraCast · host William Reed Ltd

Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup and Ginkgo Bioworks spinoff Ayana Bio. At the helm of the company is Frank Jaksch, who previously spent over two decades leading publicly-traded ingredient company ChromaDex.

Episode metadata supplied by the publisher feed · Published Dec 2, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

0:00 20:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Nutra Champions William Reed Ltd In conversation with APAC's nutrition research pioneers. A podcast brought to you by the team behind NutraIngredients-Asia.com. NutraIngredients NutraTalk Podcast William Reed Ltd Break the news on Supplements & Nutrition with NutraTalkPodcast. A podcast brought to you by the team behind NutraIngredients.com.

Frequently Asked Questions

How long is this episode of NutraIngredients NutraCast?

This episode is 20 minutes long.

When was this NutraIngredients NutraCast episode published?

This episode was published on December 2, 2022.

Can I download this NutraIngredients NutraCast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!